News

Advanced Micro Devices (NASDAQ:AMD) jumps into ARK's portfolios as Cathie Wood buys the Q2 dip and trims Palantir (PLTR) and ...
With Phase 3 results for its lead psychedelic therapy expected next year, is now the right time to take a bold bet on MNMD ...